Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Salud Publica De Mexico
|
May 13, 2021
David Barrera-Núñez, Leticia Torres-Ibarra, Leith León-Maldonado, et al.
PLOS Global Public Health
|
November 1, 2023
Sexual and reproductive health among adolescents in vulnerable contexts in Mexico: Needs, knowledge, and rights
Aremis Villalobos, Fátima Estrada, Celia Hubert, et al.
Salud Publica De Mexico
|
January 31, 2019
The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules
Eduardo Lazcano-Ponce, Martha Carnalla-Cortés, Tonatiuh Barrientos-Gutiérrez, et al.
The Journal of Nutrition
|
April 13, 2021
Diet Modulates the Effects of Genetic Variants on the Vitamin D Metabolic Pathway and Bone Mineral Density in Mexican Postmenopausal Women
Berenice Rivera-Paredez, Amado D Quezada-Sánchez, Edgar Denova-Gutiérrez, et al.
Salud Publica De Mexico
|
August 25, 2016
HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico
Jorge Salmerón, Leticia Torres-Ibarra, F Xavier Bosch, et al.
Preventive Medicine Reports
|
August 18, 2023
Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City
Leith León-Maldonado, Raúl U Hernández-Ramírez, Leticia Torres-Ibarra, et al.
Journal of Medical Virology
|
December 14, 2017
Real time PCR to evaluate HSV-2 shedding from anal and genital samples among men who have sex with men, living with HIV
Dayana N Vergara-Ortega, Edgar E Sevilla-Reyes, Antonia Herrera-Ortiz, et al.
Preventive Medicine
|
September 25, 2014
Risk factors for anal HPV-16/18 infection in Mexican HIV-infected men who have sex with men
Leticia Torres-Ibarra, Carlos J Conde-Glez, Jorge Salmerón, et al.
Human Vaccines & Immunotherapeutics
|
July 28, 2015
Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes
Mauricio Hernández-Ávila, Leticia Torres-Ibarra, Margaret Stanley, et al.
Vaccine
|
June 29, 2021
Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes
Martha Carnalla, Leticia Torres-Ibarra, Tonatiuh Barrientos-Gutiérrez, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Salud Publica De Mexico
|
May 13, 2021
David Barrera-Núñez, Leticia Torres-Ibarra, Leith León-Maldonado, et al.
PLOS Global Public Health
|
November 1, 2023
Sexual and reproductive health among adolescents in vulnerable contexts in Mexico: Needs, knowledge, and rights
Aremis Villalobos, Fátima Estrada, Celia Hubert, et al.
Salud Publica De Mexico
|
January 31, 2019
The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules
Eduardo Lazcano-Ponce, Martha Carnalla-Cortés, Tonatiuh Barrientos-Gutiérrez, et al.
The Journal of Nutrition
|
April 13, 2021
Diet Modulates the Effects of Genetic Variants on the Vitamin D Metabolic Pathway and Bone Mineral Density in Mexican Postmenopausal Women
Berenice Rivera-Paredez, Amado D Quezada-Sánchez, Edgar Denova-Gutiérrez, et al.
Salud Publica De Mexico
|
August 25, 2016
HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico
Jorge Salmerón, Leticia Torres-Ibarra, F Xavier Bosch, et al.
Preventive Medicine Reports
|
August 18, 2023
Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City
Leith León-Maldonado, Raúl U Hernández-Ramírez, Leticia Torres-Ibarra, et al.
Journal of Medical Virology
|
December 14, 2017
Real time PCR to evaluate HSV-2 shedding from anal and genital samples among men who have sex with men, living with HIV
Dayana N Vergara-Ortega, Edgar E Sevilla-Reyes, Antonia Herrera-Ortiz, et al.
Preventive Medicine
|
September 25, 2014
Risk factors for anal HPV-16/18 infection in Mexican HIV-infected men who have sex with men
Leticia Torres-Ibarra, Carlos J Conde-Glez, Jorge Salmerón, et al.
Human Vaccines & Immunotherapeutics
|
July 28, 2015
Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes
Mauricio Hernández-Ávila, Leticia Torres-Ibarra, Margaret Stanley, et al.
Vaccine
|
June 29, 2021
Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes
Martha Carnalla, Leticia Torres-Ibarra, Tonatiuh Barrientos-Gutiérrez, et al.
Page
of 4